Please login to the form below

Not currently logged in
Email:
Password:

HEOR

This page shows the latest HEOR news and features for those working in and with pharma, biotech and healthcare.

OPEN Health expands global footprint with Pharmerit International integration

OPEN Health expands global footprint with Pharmerit International integration

Pharmerit International is an expert in health economics and outcomes research (HEOR), and the integration of the company into the OPEN Health group establishes a new entity that will have capabilities ... We are delighted to welcome Pharmerit into the

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • It started with a miss It started with a miss

    What do we need to get there? Do we need a cross-functional approach that involves input from market access, HEOR, marketing etc – and at what point do we get them ... However, those approaches need to migrate out and begin to align with HEOR, medical

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    An effective launch team will be cross-functional and diverse; it’s likely to include stakeholders from regulatory, medical, marketing, HEOR and Business Intelligence, as well as sales force, country and,

  • Launch like a PRO: the art and science of successful entry to market Launch like a PRO: the art and science of successful entry to market

    From strategy to project management, market access to public affairs, governance to HEOR, they provide an incredibly thorough test of an organisation’s capability.

  • The reality of real-world evidence The reality of real-world evidence

    The rise of health technology assessment (HTA) globally puts significant emphasis on health economic and outcome research (HEOR) analysis and RWE provides critical inputs into this.

  • Choosing wisely Choosing wisely

    If it's physicians or payers, it may be medical/HEOR. If you want to talk at the corporate level, market access and public affairs may play the lead role.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 24 fully matching, plus 24 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics